Drugs for Pregnant and Lactating Women E-Book
Drugs for Pregnant and Lactating Women, 2nd Edition, by Carl P. Weiner, MD, MBA, FACOG, and Catalin Buhimschi, MD, is a must-have reference that details how virtually all of today s drugs and herbal supplements interact with pregnancy and lactation. Updated thoroughly and covering nearly 2,000 substances, the new edition explains whether each drug is FDA-approved for use by expecting or nursing mothers...is known to be safe for use...or is known to pose a danger. An alphabetical organization by both trade and generic name...a special index listing drugs by category...and an easy-to-read page format make reference more efficient.Describes each substance's mechanism of action, side effects, drug-drug interactions, dosage, cost of therapy, and degree of safety during pregnancy or lactation, providing the thorough details you need to choose the most effective course of treatment. Indicates not only whether the FDA has approved a drug based on clinical trials, but also whether the drug is generally considered to be safe in the absence of FDA approval. Includes over-the-counter drugs and alternative medications as well as prescription drugs, to give you a broad background of available drugs. Features an alphabetical organization by both trade and generic name...a special index listing drugs by category...and an easy-to-read page format that make reference more efficient. Uses an eye-catching icon to highlight known teratogens. Examines new drugs that have been introduced to the market since the publication of the previous edition, and presents revised or new information for all current listings, to keep you current. Provides drug interaction information to make you aware of the possible implications of using more than one drug in combination. Includes international drug names to give this reference an international perspective.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
adequate reports adequatereports or well-controlled Argentina Australia Austria Belgium benefit justifies Brazil breast milk Breastfeeding Safety Bulgaria buspirone Canada cephalosporins Chile Clin clinically Colombia Contraindications—hypersensitivity to drug crosses the human Czech Republic Denmark Dosage with Qualifiers Drug Interactions drug or class Ecuador enters human breast evidence of teratogenicity excreted Fetal Considerations Finland France Germany Greece Guatemala hepatic Honduras Hong Kong human breast milk human fetuses human placenta increase India Indications Indonesia infections International Brand Name Israel Italy Japan justifies the potential Korea Lactation Lactation Category Malaysia Maternal Considerations Mechanism metabolism Mexico neonatal Netherlands Nicaragua nursing women Obstet Gynecol Paraguay Peru Philippines placenta Portugal potential perinatal risk pregnancy and lactation Pregnancy Category pregnant women Probenecid prophylaxis published experience reports or well-controlled Rodent Rodent studies seizures Side effects include Singapore South Africa Spain studies are reassuring studies in human Summary Pregnancy Category Sweden Switzerland Taiwan teratogenicity Thailand thrombocytopenia unknown Uruguay Venezuela